Lexicon Pharmaceuticals Surpasses Earnings Expectations, Signals Potential Turnaround Amid Volatility
Lexicon Pharmaceuticals Inc has surpassed second-quarter earnings expectations, signaling a potential turnaround for the beleaguered biopharmaceutical company.
3 minutes to read